Skip to content
The GLP-1 Verdict
Menu
Ranked #29 · Grade B

Henry Meds review

A flat-fee compounded pioneer — simple model, but priced at the higher end now.

Visit Henry Meds Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only

The scorecard

Henry Meds scored on our six published factors. See the methodology.

Real-world results85/100
Price honesty85/100
Prescriber access84/100
Formulary choice82/100
Cancellation fairness84/100
Member support84/100

What we like

  • Simple flat-fee model
  • Well-established brand
  • Both molecules

The caveats

  • Higher pricing than many newer entrants
  • Compounded only

The verdict

Best for: People who want a simple, well-known flat-fee compounded program. A flat-fee compounded pioneer — simple model, but priced at the higher end now.

Ranked #29 of 509 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. On the board it sits between Alan Meds, 84/100 above and bmiMD at 83/100 below, with the Live Vital ruling the next one down.

Weighing it against something else? Every provider we would put in front of Henry Meds is ranked on price honesty, prescriber access and cancellation terms. We have also ruled on it directly: CoreAge Rx vs Henry Meds goes to CoreAge Rx, 94/100 to 84/100.

Visit Henry Meds

Compare with other providers

All 508 other providers we've reviewed, in our overall ranking order.

Every other program we track (502)

Pricing, states and verification reflect Henry Meds's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.

← Back to all rankings